Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022.

Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022.

Publication date: Aug 01, 2024

This study estimated the benefits and costs of the U. S. Department of Health and Human Services’ We Can Do This COVID-19 public education campaign (the Campaign) and associated vaccination-related impacts. Weekly media market and national Campaign expenditures were used to estimate weekly first-dose vaccinations that would not have occurred absent the Campaign, weekly Campaign-attributed complete vaccinations, and corresponding COVID-19 cases, hospitalizations, and deaths averted. Benefits were valued using estimated morbidity and mortality reductions and associated values of a statistical life and a statistical case. Costs were estimated using Campaign paid media expenditures and corresponding vaccination costs. The net Campaign and vaccination benefit and return on investment were calculated. Analyses were conducted from 2022 to 2024. Between April 2021 and March 2022, an estimated 55. 9 million doses of COVID-19 vaccines would not have been administered absent the Campaign. Campaign-attributed vaccinations resulted in 2,576,133 fewer mild COVID-19 cases, 243,979 fewer nonfatal COVID-19 hospitalizations, and 51,675 lives saved from COVID-19. The total Campaign benefit was $740. 2 billion, and Campaign and vaccination costs totaled $8. 3 billion, with net benefits of approximately $732. 0 billion. For every $1 spent, the Campaign and corresponding vaccination costs resulted in benefits of approximately $89. 54. The We Can Do This COVID-19 public education campaign saved more than 50,000 lives and prevented hundreds of thousands of hospitalizations and millions of COVID-19 cases, representing hundreds of billions of dollars in benefits in less than one year. Findings suggest that public education campaigns are a cost-effective approach to reducing COVID-19 morbidity and mortality.

Concepts Keywords
April Cost-Benefit Analysis
Covid COVID-19
Hospitalizations COVID-19 Vaccines
Weekly COVID-19 Vaccines
Health Promotion
Hospitalization
Humans
SARS-CoV-2
United States
Vaccination

Semantics

Type Source Name
disease MESH COVID-19
disease VO vaccination
disease VO dose
disease MESH morbidity
disease VO effective
disease MESH Long Covid

Original Article

(Visited 1 times, 1 visits today)